TY  - JOUR
T1  - WEight watching in heparin
AU  - Cheng TO
Y1  - 1999/05/24
N1  - 
JO  - Archives of Internal Medicine
SP  - 1142
EP  - 1142
VL  - 159
IS  - 10
N2  - 
This success of LMWH in the management of DVT has prompted several investigators to study the use of LMWH in acute coronary syndromes. Three recently completed trials—the FRagmin during InStability in Coronary artery disease study (FRISC),4 the Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-wave Coronary Events study (ESSENCE),5 and the FRagmin In unstable Coronary artery disease study (FRIC)6—concluded that treatment of patients with unstable angina with LMWH is at least as effective as and potentially more effective than with unfractionated heparin.

SN  - 0003-9926
M3  - doi: 
UR  - http://dx.doi.org/
ER  -